CORDIS
EU research results

CORDIS

English EN

IN-CYTES A HIGH-DENSITY MICROELECTRODE ARRAY PLATFORM FOR LARGE-SCALE INTRACELLULAR FUNCTIONAL ASSAYS

Objective

MaxWell Biosystems AG (MxW) is a Swiss public limited company (AG) who developed electrophysiological platforms (hardware-software-bioassays) for basic research and drug testing on nerve cells. MxW’s aim is to develop In-Cytes, a radically innovative electrophysiology platform to assess neural connectivity for preclinical drug discovery for brain diseases. In contrast to the state-of-the-art technologies for quantifying neural connectivity, which either estimate indirect connectivity or feature poor spatial resolution, In-Cytes can measure physiological direct neural intracellular connectivity among thousands of neurons. This directly addresses the industrial need in pharmacy for neural connectivity bioassays, featuring high-throughput and minimum interference with neurons’ physiology for the development of effective drugs to cure neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases.

The proposed recruitment of an Innovation Associate will have significant impact on the business opportunities of MxW by bringing in lacking expertise for the development of In-Cytes. The envisaged grant will help to overcome the recruitment barriers of being a relatively unknown, small start-up enterprise that cannot compete with larger companies due to limited visibility, brand awareness, (perceived) career opportunities, salary and recruitment budget.

The development of In-Cytes requires the employment of an academic expert with a multidisciplinary set of skills combining knowledge in neuroscience, microfabrication and data analysis. In turn, the innovation associate will have the opportunity to become an expert in the emerging field of bio-engineering. It is in the interest of the company to continue the employment after the initial year in order to develop the first prototype of In-Cytes into an industrial end product.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

MAXWELL BIOSYSTEMS AG

Address

Mattenstrasse 26
4058 Basel

Switzerland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 135 500

Project information

Grant agreement ID: 861712

Status

Grant agreement signed

  • Start date

    15 October 2019

  • End date

    14 October 2020

Funded under:

H2020-EU.2.3.2.2.

  • Overall budget:

    € 135 500

  • EU contribution

    € 135 500

Coordinated by:

MAXWELL BIOSYSTEMS AG

Switzerland